Defective chylomicron synthesis as a cause of delayed particle clearance in diabetes?

International Journal of Experimental Diabetes Research

Volumn 3, Issue 3, 2002, Pages 171-178

  Phillips, Catherine ^a   Madigan, Claire ^a   Owens, Daphne ^a   Collins, Patrick ^a   Tomkin, Gerald H ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Apolipoprotein B100; Apolipoprotein B48; Apolipoprotein E; Cholesterol turnover; Chylomicron turnover; Triglyceride turnover; Type 2 diabetes

Indexed keywords

ALLOXAN; APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; APOLIPOPROTEIN E; CHOLESTEROL; CHYLOMICRON; INSULIN ZINC SUSPENSION; LINOLEIC ACID; TRIACYLGLYCEROL;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CANNULATION; CONTROLLED STUDY; ISOTOPE LABELING; LYMPH; LYMPH VESSEL; MALE; NONHUMAN; PLASMA CLEARANCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN SYNTHESIS; TRIACYLGLYCEROL BLOOD LEVEL; ULTRACENTRIFUGATION;

ANIMALS; APOLIPOPROTEIN B-100; APOLIPOPROTEIN B-48; APOLIPOPROTEINS B; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; CHOLESTEROL; CHYLOMICRONS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; LYMPH; MALE; RABBITS; REFERENCE VALUES; TIME FACTORS; TRIGLYCERIDES;

EID: 0036662380     PISSN: 15604284     EISSN: None     Source Type: Journal    
DOI: 10.1080/15604280214277     Document Type: Article

References (28)

1. Tomkin, G. H., and Owens, D. (2001) ApoB lipoproteins, diabetes and atherosclerosis. Diabetes Metab. Rev., 17, 27-43.
2. Takeichi, S., Yukawa, N., Nakajima, Y., Osawa, M., Saito, T., Seto, Y., Nakano, T., Saniabadi, A. R., Adachi, M., Wang, T., and Nakajima, K. (1999) Association of plasma triglyceride-rich lipoprotein remnants with coronary atherosclerosis in cases of sudden cardiac death. Atherosclerosis, 142, 309-315.
3. Shaw, H. E., Hodge, A. M., deCourten, M., Chitson, P., and Zimmet, P. Z. (1999) Isolated postchallenge hyperglycaemic confirmed as a risk factor for mortality. Diabetologia, 42, 1050-1054.
4. Anderson, J. H., Brunelle, R. L., Koivisto, V. A., Pfutzner, A., Trautmann, M. E., Vignati, L., DiMarchi, R., and the Multicenter Insulin Lispro Study Group (1997) Reduction of post-prandial hyperglycaemia and frequency of hypoglycaemia in IDDM patients on insulin-analog treatment. Diabetes, 46, 265-270.
5. Curtin, A., Deegan, P., Owens, D., Collins, P., Johnson, A., and Tomkin, G. H. (1994) Alterations in apolipoprotein B-48 in the post-prandial state. Diabetologia, 37, 1259-1262.
6. Curtin, A., Lenihan, K., Deegan, P., Owens, D., Johnson, A., Collins, P., and Tomkin, G. H. (1995) Intestinally derived lipoprotein particles in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia. Acta Diabetologica, 32, 244-250.
7. Curtin, A., Deegan, P., Owens, D., Johnson, A., Collins, P., and Tomkin, G. H. (1996) Elevated triglyceride-rich lipoproteins in diabetes: A study of apo B48. Acta Diabetologica, 33, 205-210.
8. Taggart, C., Gibney, J., Owens, D., Collins, P., Johnson, A., and Tomkin, G. H. (1997) The role of dietary cholesterol in the regulation of post-prandial apolipoprotein B48 levels in diabetes. Diabetic Medicine, 14, 1051-1058.
9. Levy, E., Shafrif, E., Ziv, E., and Bar-On, H. (1983) Composition, removal and metabolic fate of chylomicrons derived from diabetic rats. Biochim. Biophys. Acta, 834, 376-385.
10. Feingold, K. R., Lear, S. R., and Felts, J. M. (1986) The disappearance from the circulation of chylomicrons obtained from control and diabetic rats. Endocrinology, 121, 475-480.
11. Weisgraber, K. H. (1994) Apoprotein E: Structure-function relationships. Adv. Protein Chem., 45, 249-302.
12. Yen, F. T., Mann, C. J., Guermani, L. M., Hannouche, N. F., Hubert, N., and Hornick, C. A. (1994) Identification of a lipolysis-stimulated receptor that is distinct from the LDL receptor and the LDL receptor-related protein. Biochemistry, 33, 1172-1180.
13. Mahley, R. W., and Ji, Z.-S. (1999) Remnant lipoprotein metabolism: Key pathway involving cell surface heparin sulphate proteoglycans and apolipoprotein E. J. Lipid Res., 40, 1-16.
14. Lenich, C. M., Chobanian, A. V., Brecher, P., and Zannis, V. I. (1991) Effect of dietary cholesterol and alloxan-diabetes on tissue cholesterol and apolipoprotein E mRNA levels in the rabbit. J. Lipid Res., 32, 431-438.
15. Yamamoto, K., Shimano, H., Shimada, M., Kawamura, M., Gotoda, T., Harada, K., Ohsuga, Ji., Yazaki, Y., and Yamada, N. (1995) Overexpression of apolipoprotein E prevents development of diabetic hyperlipidaemia in transgenic mice. Diabetes, 44, 580-585.
16. Finking, G., and Hanke, H. (1997) Nickolaj Nikolajewitisch Anitschkow (1885-1964) established the cholesterol-fed rabbit as a model for atherosclerosis research. Atherosclerosis, 135, 1-7.
17. Markwell, M. A. K., Haas, S. M., Bieber, L. L., and Tolbert, N. E. (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem., 87, 206-210.
18. Phillips, C., Murugasu, G., Owens, D., Collins, P., Johnson, A., and Tomkin, G. H. (2000) Improved metabolic control reduces the number of postprandial apolipoprotein B48-containing particles in Type 2 diabetes. Atherosclerosis, 148, 283-291.
19. Kotite, L., Bergeron, N., and Havel, R. J. (1995) Quantitation of apolipoproteins B100, B48 and E in human triglyceride-rich lipoproteins. J. Lipid Res., 36, 890-900.
20. Bocan, T. M., Mueller, S. B., Mazur, M. J., Uhlendorf, P. D., Brown, E. Q., and Kieft, K. A. (1993) The relationship between the degree of dietary induced hypercholesterolaemia in the rabbit and atherosclerotic lesion formation. Atherosclerosis, 102, 9-22.
21. Greeve, J., Altkemper, I., Dieterich, J.-H., Greten, H., and Windler, E. (1993) Apolipoprotein B editing in 12 different mammalian species: Hepatic expression is reflected in low concentrations of apo B-containing plasma lipoproteins. J. Lipid Res., 34, 1367-1376.
22. Hasty, A. H., Linton, M. R. F, Swift, L. L., and Fazio, S. (1999) Determination of the lower threshold of apolipoprotein E resulting in remnant lipoprotein clearance. J. Lipid Res., 40, 1529-1538.
23. Weisgraber, K. H., Innerarity, T. L., and Maley, R. W. (1982) Abnormal lipoprotein receptor binding activity of human E apoprotein due to cysteine-arginine interchange at a single site. J. Biol. Chem., 257, 2818-2821.
24. Syvanne, M., Rosseneu, M., Labeur, C., Hilden, H., and Taskinen, M. R. (1994) Enrichment with apo E characterises postprandial TG-rich lipoproteins in patients with non-insulin-dependent diabetes mellitus and coronary artery disease; a preliminary report. Atherosclerosis, 105, 25-34.
25. Redgrave Mamo, J. C. L., Hirano, T., Sainsbury, A., Fitzgerald, A. K., and Redgrave, T. G. (1992) Hypertriglyceridaemia is exacerbated by slow lipolysis of triglycerol-rich lipoproteins in fed but not fasted streptozotocin diabetic rats. Biochim. Biophys. Acta, 1128, 132-138.
26. Chait, A., Beirman, E. L., and Albers, J. J. (1997) Low density lipoprotein receptor activity in cultured skin fibroblasts: Mechanisms of insulin induced stimulation. J. Clin. Invest., 64, 1309-1319.
27. Eckel, R. H. (1989) Lipoprotein lipase: A multifunctional enzyme relevant to common metabolic diseases. N. Engl. J. Med., 320, 1060-1068.
28. Demacker, P. N. M., Bredie, S., Vogelaar, J. M., Hectors, M., van Heijst, P., Stuyt, P., and Stalenhoef, A. (1981) β-VLDL accumulation in familial dysbetalipoproteinaemia is associated with increased exchange or diffusion of chylomicron lipids to apo B100 containing triglyceride-rich lipoproteins. Atherosclerosis, 38, 301-312.